EMILY WALDKOETTER: Open Payments
NPI 1164134136 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,040 in 101 payments from 26 companies in 2025. Trend: 2023 $240 · 2024 $2,349 · 2025 $2,040
Food & beverage: $2,040
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $370 |
| AstraZeneca Pharmaceuticals LP | 8 | $273 |
| Novo Nordisk Inc | 12 | $267 |
| Amgen Inc. | 12 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $137 |
| HEARTFLOW, INC. | 1 | $125 |
| Lilly USA, LLC | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $53 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, OTEZLA, FFRct, QULIPTA, VRAYLAR, MOUNJARO.
Industry payments across IN — which companies pay providers there.
